Surveys

What’s really holding back healthcare M&A?

Healthcare M&A Is Poised for a Recovery in 2026. The Industry Still Sees Three Structural Barriers Standing in the Way.

Home Healthcare

How Aging Demographics, AI, and Decentralized Care Are Transforming the Future of Global Healthcare

Healthcare’s Margin Playbook Is Getting More Selective

Margin protection in healthcare used to mean one thing: cut costs faster than revenue slows.

Regulatory Burden Remains a Material Drag on Healthcare Efficiency, with Physicians Feeling the Greatest Strain

Healthcare leaders consistently cite regulation as both a safeguard and a source of operational drag.

Margin Pressure Is No Longer a Sector Story. It Is a Business Model Story.

Biggest Cost Drivers in Healthcare

No Single Culprit — Layered Pressures Are Driving Costs Higher

Healthcare M&A Strategy Is Shifting Toward Discipline

Healthcare dealmaking hasn’t stopped — but the playbook is clearly evolving.

What Will Matter Most for Successful Healthcare M&A in This Cycle?

In a market defined by higher rates, tighter capital, and increased regulatory scrutiny, healthcare M&A is no longer just about finding the right asset — it’s about managing complexity after the deal closes

Where Healthcare M&A Is Most Likely to Hold Up in 2026

Healthcare dealmaking may be slower and more selective, but it’s far from stalled.

What Will Really Slow Healthcare M&A in the Next 12 Months?

Healthcare dealmaking isn’t short on capital—or targets. What it is short on is certainty.